Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study

INTRODUCTION: There is scant real-world information on switching treatment for anemia associated with chronic kidney disease (CKD) from methoxy polyethylene glycol-epoetin beta (PEG-Epo) to darbepoetin alfa (DA). TRANSFORM was a multi-center, observational study designed to describe the time course...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Donck, Jan, Gonzalez-Tabares, Lourdes, Chanliau, Jacques, Martin, Heike, Stamatelou, Kyriaki, Manamley, Nick, Farouk, Mourad, Addison, Janet
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4245491/
https://ncbi.nlm.nih.gov/pubmed/25367412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-014-0161-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados